Amanda Cray
Investor Relations Contact at FUSN PHAR
Profile
Amanda Cray is currently a Senior Director-IR & Corporate Communications at Fusion Pharmaceuticals, Inc. Prior to her current position, she worked as an Associate Director-IR & Corporate Communications at Aegerion Pharmaceuticals, Inc. from 2012 to 2019, and as a Director-IR & Corporate Communications at Novelion Therapeutics, Inc. from 2016 to 2019.
Before that, she worked as a Senior Account Executive at LaVoie Strategic Communications Group, Inc., an Associate at Sharon Merrill Associates, Inc., and an Account Manager at Harron & Associates, Inc. Ms. Cray received a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.
Amanda Cray active positions
| Companies | Position | Start |
|---|---|---|
| FUSN PHAR | Investor Relations Contact | - |
Former positions of Amanda Cray
| Companies | Position | End |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Investor Relations Contact | 2019-06-30 |
| NOVELION THERAPEUTICS INC. | Investor Relations Contact | 2019-06-30 |
Sharon Merrill Associates, Inc.
 Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Sharon Merrill Associates, Inc. is a full-service investor relations and corporate communications strategic advisory agency. Sharon Merrill Associates is based in Boston, MA. The private company has an international reputation as a preeminent strategic IR advisory firm. Sharon Merrill partners with IROs and the C-suite to drive value for both external and internal stakeholders. Clients have relied on their senior-level counsel and communications expertise for more than 35 years to guide them through every challenge and meet every opportunity. The company takes a strategic approach to every situation as they leverage sophisticated stakeholder engagement and innovative digital media, social media, and branding strategies to help clients build enduring and value-creating relationships with the right audiences. Maureen T. Wolff has been the CEO of the company since 1985. | Corporate Officer/Principal | - |
| Harron & Associates, Inc. | Corporate Officer/Principal | - |
LaVoie Strategic Communications Group, Inc.
 LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services LaVoie Strategic Communications Group, Inc. provides strategic communications programs, strategy and brand positioning services to the life science and pharmaceutical clients. It offers marketing strategy, investor and public relations, corporate communications, and consulting services. The firm provides program planning, website content development, product launch, investor targeting, corporate positioning, annual reports, and executive counsel consulting services. The company was founded in 2001 by Donna L. LaVoie and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Amanda Cray
| Boston University | Graduate Degree |
| University of New Hampshire | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FUSN PHAR | Health Technology |
| Private companies | 5 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
LaVoie Strategic Communications Group, Inc.
LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services LaVoie Strategic Communications Group, Inc. provides strategic communications programs, strategy and brand positioning services to the life science and pharmaceutical clients. It offers marketing strategy, investor and public relations, corporate communications, and consulting services. The firm provides program planning, website content development, product launch, investor targeting, corporate positioning, annual reports, and executive counsel consulting services. The company was founded in 2001 by Donna L. LaVoie and is headquartered in Boston, MA. | Commercial Services |
Sharon Merrill Associates, Inc.
Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Sharon Merrill Associates, Inc. is a full-service investor relations and corporate communications strategic advisory agency. Sharon Merrill Associates is based in Boston, MA. The private company has an international reputation as a preeminent strategic IR advisory firm. Sharon Merrill partners with IROs and the C-suite to drive value for both external and internal stakeholders. Clients have relied on their senior-level counsel and communications expertise for more than 35 years to guide them through every challenge and meet every opportunity. The company takes a strategic approach to every situation as they leverage sophisticated stakeholder engagement and innovative digital media, social media, and branding strategies to help clients build enduring and value-creating relationships with the right audiences. Maureen T. Wolff has been the CEO of the company since 1985. | Commercial Services |
| Harron & Associates, Inc. | |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Amanda Cray
